The U.S. Food and Drug Administration approved UZEDY (risperidone) extended-release injectable suspension for maintenance treatment of bipolar I disorder in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE